Morphosys
MONJUVI
Manufacturer:
Morphosys
Name:
MONJUVI
HCPCS Code Descriptor:
Injection, tafasitamab-cxix, 2 mg
Category:
J Code
HCPCS:
J9349
NDC(s):
73535-0208-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
MONJUVI is an Oncology drug manufactured by Morphosys and administered via the Intravenous route of administration. The J Code: J9349 is aligned to the drug MONJUVI.
Access Pricing and More By Registering
HCPCS Added Date:
4/1/21
HCPCS Effective Date:
4/1/21
HCPCS Short Description:
Inj., tafasitamab-cxix
Billing and Coding Guide:
https://www.monjuvihcp.com/pdfs/Billing-and-Coding-Guide.pdf
Patient Assistance:
https://www.mymissionsupport.com/
